Results 231 to 240 of about 9,529,278 (349)
Intratumour heterogeneity complicates precision management of advanced endometrial cancer. Circulating tumor DNA (ctDNA) offers a minimally invasive strategy to capture tumor evolution and therapeutic resistance. Here, we compare tumor‐agnostic NGS with tumor‐informed ddPCR, outlining their relative sensitivity, concordance, and clinical implications ...
Carlos Casas‐Arozamena +15 more
wiley +1 more source
Functionalization of Fast-Charging Hard Carbon Anode for Ah-Level Li-Ion Pouch Batteries. [PDF]
Cui Y +11 more
europepmc +1 more source
Here, we demonstrate that HS1BP3 interacts with Cortactin through a proline‐rich region (PRR3.1) and show that this interaction, and HS1BP3 itself, promote cancer cell proliferation and invasion. Inhibition of this interaction leads to build‐up of TKS5 in multivesicular endosomes and altered secretion of CD63 and CD9, providing an explanation for the ...
Arja Arnesen Løchen +9 more
wiley +1 more source
Characterizing many-body dynamics with projected ensembles on a superconducting quantum processor. [PDF]
Yan Z +5 more
europepmc +1 more source
Photovoltaic materials: Present efficiencies and future challenges
A. Polman +4 more
semanticscholar +1 more source
Translational cancer research and its implementation through competitively selected Comprehensive Cancer Centers across Europe should be the primary policy focus for addressing the increasing cancer burden in Europe and counteract the present main strategy to convert cancer to a chronic disease.
Manuel Heitor +2 more
wiley +1 more source
Direct generation of massive vector-mode entanglement from a polarization-insensitive optical amplifier. [PDF]
Wang X, Wei Y, Zhang K, Pan X, Jing J.
europepmc +1 more source
Big data are shaping the future of materials science
Ashley A. White
semanticscholar +1 more source
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata +10 more
wiley +1 more source

